← All Bicycle Therapeutics PLC filings

Bicycle Therapeutics PLC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
BCYC
Bicycle Therapeutics PLC
DEF: Bicycle Therapeutics Sets June 17 AGM Date
Bicycle Therapeutics plc has announced its 2026 Annual General Meeting will be held on June 17, 2026, to vote on director re-elections, executive compensation, and auditor appointments.
NASDAQ
BCYC
Bicycle Therapeutics PLC
DEF: Bicycle Therapeutics Seeks Shareholder Approval for Key Proposals at 2025 AGM
Bicycle Therapeutics is holding its 2025 Annual General Meeting on June 17, 2025, seeking shareholder votes on director re-elections, executive compensation, auditor appointments, and an equity incentive plan amendment.
NASDAQ
BCYC
Bicycle Therapeutics PLC
DEFA14A: Bicycle Therapeutics Appoints Felix J. Baker to Board, Enters Registration Rights Agreement with Baker Brothers Funds
Bicycle Therapeutics plc announced the appointment of Felix J. Baker, Ph.D. to its Board of Directors and the execution of a registration rights agreement with Baker Brothers funds, granting them certain resale registration rights.
NASDAQ
BCYC
Bicycle Therapeutics PLC
DEF 14A: Bicycle Therapeutics Seeks Shareholder Approval for Director Re-elections, Executive Pay, Auditor Ratification, and Amendments to Articles of Association
Bicycle Therapeutics has scheduled its 2024 Annual General Meeting (AGM) for May 16, 2024, seeking shareholder approval on key proposals including director re-elections, executive compensation, auditor ratification, and adoption of new articles of association.